Metabolic syndrome is not a single disease. It's a cluster of five interconnected risk factors that, when they occur together, dramatically increase your risk of heart attack, stroke, type 2 diabetes, and premature death. About 35% of US adults met the criteria in national survey data from 2011–2016. Many don't know it.
The five criteria
You have metabolic syndrome if you meet three or more of these five criteria:
- Waist circumference: ≥102 cm in men, ≥88 cm in women (US thresholds; for people of European origin, the international definition also allows lower cut-offs of ≥94 cm and ≥80 cm)
- Triglycerides: ≥150 mg/dL (or on medication for elevated triglycerides)
- HDL cholesterol: <40 mg/dL in men, <50 mg/dL in women
- Blood pressure: ≥130/85 mmHg (or on antihypertensive medication)
- Fasting glucose: ≥100 mg/dL (or on medication for elevated glucose)
Each of these, individually, is a risk factor. But together they're more than the sum of their parts. Metabolic syndrome roughly doubles your cardiovascular risk and increases your diabetes risk about fivefold compared with people who do not have the syndrome.
Why it matters more than individual numbers
The power of the metabolic syndrome diagnosis is pattern recognition. A fasting glucose of 105, triglycerides of 170, HDL of 38, and a waist circumference of 106 cm — each of these is "borderline" individually. None would trigger aggressive treatment on its own. But together, they form a pattern that says: this person has insulin resistance, and their cardiovascular clock is ticking faster than their individual numbers suggest.
The underlying driver, in most cases, is insulin resistance. The visceral fat around your organs produces inflammatory cytokines, disrupts lipid metabolism, raises blood pressure, and eventually overwhelms the pancreas's ability to compensate. Metabolic syndrome is, in many ways, the external manifestation of what HOMA-IR measures internally.
A patient with metabolic syndrome and "borderline" numbers everywhere is at higher risk than any single value suggests — sometimes higher than a patient with one moderately elevated number and everything else normal. The pattern matters, not just the single value.
Why standard check-ups miss it
The metabolic syndrome diagnosis requires measuring all five components and interpreting them as a cluster. Most standard check-ups measure blood pressure and fasting glucose — but they may not measure triglycerides and HDL (some panels only include total cholesterol), they rarely measure waist circumference, and even when all values are available, the physician may look at each one individually and say "everything's borderline but fine" rather than recognizing the pattern.
What a thorough assessment includes
Capturing metabolic syndrome is not complicated: all five criteria come from a tape measure, a blood pressure cuff and a standard fasting blood test. Some physicians add HOMA-IR, which can detect the underlying insulin resistance even earlier. Body composition analysis can add an estimate of visceral fat, which correlates closely with metabolic risk.
If three or more criteria are met — or if insulin resistance is evident even without formal metabolic syndrome — a sensible next step is a closer look at the organs most affected: an abdominal ultrasound to assess liver fat, a precise body composition measurement such as DEXA, and an extended lipid panel. What matters most is a structured plan that targets the specific abnormalities found. Questions worth asking your doctor:
- Do my results meet three or more of the five criteria?
- Has my waist circumference been measured, and are my HDL and triglycerides known — not just total cholesterol?
- Would a liver ultrasound or further tests be useful in my case?
The good news
Metabolic syndrome is often at least partly reversible with lifestyle intervention — especially if caught early. The Diabetes Prevention Program showed that moderate weight loss (7%) and 150 minutes of weekly exercise reduced progression to diabetes by 58% in people with prediabetes. In the same trial, the lifestyle programme cut new cases of metabolic syndrome by 41%, and its prevalence fell from 53% to 43% over three years, while it rose from 55% to 61% with placebo. The hard part isn't the treatment — it's knowing you need it.
References
- Alberti KGMM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640-1645.
- Mottillo S, et al. The metabolic syndrome and cardiovascular risk: a systematic review and meta-analysis. J Am Coll Cardiol. 2010;56(14):1113-1132.
- Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393-403.
- Orchard TJ, et al. The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial. Ann Intern Med. 2005;142(8):611-619.
This article is general information and not individual medical advice. Decisions about tests and treatment belong in a conversation with your own physician.